choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Tenecteplase

Tenecteplase Newsletter
  • Tenecteplase Matches Alteplase for Ischemic Stroke Care 28 Mar 2025 10:27 GMT

    … : After adjusting for covariates, tenecteplase and alteplase showed comparable effectiveness … EVT), those treated with tenecteplase showed significantly greater improvements in … , with practical advantages for tenecteplase preparation and administration,” the …

  • Tenecteplase Matches Alteplase in Safety and Effectiveness for Acute Ischemic Stroke, Study Finds 23 Mar 2025 18:35 GMT

    … safety and effectiveness of intravenous tenecteplase versus alteplase in patients with … mortality/hospice discharge. However, tenecteplase showed benefits among patients eligible … Term Safety and Effectiveness for Tenecteplase and Alteplase in Acute …

  • Global Tenecteplase TNKase Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034 19 Mar 2025 15:43 GMT

    … and pre-existing conditions. Tenecteplase TNKase, a tissue plasminogen … 47;report/tenecteplase-tnkase-global-market-report … factor influencing the tenecteplase TNKase market. The increasing … obesity and diabetes. Tenecteplase TNKase helps patients by …

  • Special Episode: FDA Approves Tenecteplase for Acute Ischemic Stroke 12 Mar 2025 19:27 GMT

    … ;s recent approval of tenecteplase, marketed as TNKase (Genentech), for the … Immediate reaction and significance of tenecteplase approval 5:30 – Safety … considerations and administration when prescribing tenecteplase 10:20 – Supportive efficacy …

  • FDA approves Genentech’s TNKase in acute ischemic stroke 07 Mar 2025 18:22 GMT

    … (FDA) has approved Genentech’s TNKase (tenecteplase), a thrombolytic or clot-dissolving … non-inferiority study demonstrating that TNKase is comparable to Activase in … AcT (Alteplase compared to Tenecteplase) trial compared TNKase to Activase in treating …

  • FDA Approves TNKase for Acute Ischemic Stroke 06 Mar 2025 21:07 GMT

    … and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot … Genentech, the manufacturer of TNKase, says a new 25- … deficit. Results show that TNKase was comparable to Activase … stroke." Approval of TNKase was granted to Genentech. …

  • Roche’s Genentech granted FDA approval for TNKase in acute ischaemic stroke 05 Mar 2025 12:46 GMT

    … Drug Administration (FDA) for TNKase (tenecteplase) in acute ischaemic stroke … receiving oxygen and nutrients. TNKase is a tissue plasminogen … inferiority study demonstrating that TNKase is comparable to … options for patients. “TNKase provides a faster and …

  • FDA Approves Tenecteplase as First Stroke Drug in Nearly 30 Years 05 Mar 2025 07:19 GMT

    … AcT (Alteplase compared to Tenecteplase) trial compared TNKase to Activase in treating … infarction (STEMI) in adults. About TNKase® (tenecteplase) TNKase® (tenecteplase) is a tissue plasminogen activator …

  • FDA approves TNKase for acute ischemic stroke in adults 04 Mar 2025 20:11 GMT

    … in a press release that TNKase (tenecteplase) has been approved as … Genentech, the release said. Tenecteplase is the first acute … IV bolus infusion of tenecteplase for adults with acute … AcT (Alteplase compared to Tenecteplase), conducted by the University of …

  • FDA Approves Genentech’s TNKase for Acute Ischemic Stroke in Adults 04 Mar 2025 15:19 GMT

    … Drug Administration (FDA) has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving … medicines for AIS, TNKase and Activase (alteplase). TNKase is delivered as … AcT (Alteplase compared to Tenecteplase) trial compared TNKase to Activase in treating …

Satisfied with the content?

Continue to create your account.